QuellTX
Styliani Rontogianni is an experienced QC Scientist currently employed at Quell Therapeutics since September 2024. Previously, Styliani held the position of Senior QC Scientist at Autolus Ltd. from August 2021 to September 2024, where expertise in Data Integrity and GDocP was demonstrated through the implementation of projects focused on documentation and cGMP skills within the QC department. Prior to that, Styliani worked at Labcorp Drug Development as QC Analyst II, specializing in Protein Chemistry, ensuring compliance with regulatory requirements and delivering high-quality data. Styliani also served as QC Analyst I at Attikon University General Hospital, engaging in microbiology and biochemistry tasks, alongside responsibilities in blood drawing. Styliani holds a Master of Science in Stem Cell and Regenerative Medicine from The University of Sheffield and a Bachelor's degree in Biomedical Sciences from the University of West Attica.
This person is not in any teams
QuellTX
4 followers
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cellengineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.